Fact CheckerSign in

NCT07266935Completed

Posterior Pericardiotomy for Prevention of POAF After Cardiac Surgery: RCT in Yemen

A Prospective, Randomized Controlled Trial Evaluating the Effectiveness of Posterior Pericardiotomy in Preventing Postoperative Atrial Fibrillation Among Yemeni Cardiac Surgical Patients

Source: ClinicalTrials.gov · Last updated 5 Dec 2025

Brief summary (registry, in English)

A single-center, randomized controlled trial in Yemen evaluating whether posterior pericardiotomy (PP) reduces postoperative atrial fibrillation (POAF) after open-heart surgery. 210 patients undergoing CABG, aortic valve replacement, ascending aortic surgery, or combined procedures were randomized 1:1 to receive either posterior pericardiotomy (PP group, n = 106) or standard care (control group, n = 104). Outcomes assessed included POAF incidence, pericardial effusion, cardiac tamponade, ICU stay, mechanical ventilation, in-hospital mortality, and re-exploration for bleeding or tamponade.

Status (registry)
Completed
Study type
Interventional
Enrollment
210 (actual)
First submitted
26 Sept 2025
Start date
1 Jan 2022
Primary completion date
30 Jun 2024
Lead sponsor
Taiz University - Faculty of Medicine
NCT number
NCT07266935

What you commit to

  • Study type: Interventional
  • Participants enrolled: 210
  • From 1 Jan 2022 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous cardiac or thoracic surgery
  • Mitral or tricuspid valve surgery (excluded due to distinct pathophysiology and POAF risk)

Other illness

  • Preoperative atrial fibrillation or other rhythm disorders

Lab values

  • Renal failure with plasma creatinine \>2.0 mg/dL

Other

  • Left-sided pleural adhesions
  • Hyperthyroidism
  • Off-pump CABG
  • Refusal to participate

Who the study is looking for

  • Age ≥18 years.
  • Elective open-heart surgery:
    • Coronary artery bypass grafting (CABG) Aortic valve replacement Ascending aortic surgery Combined procedures (e.g., CABG + valve replacement)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cardiovascular & Kidney Transplantation Centre, Taiz University, Taiz, Yemen
Coordinator of this site? Confirm its status
TaizYemenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.